Streetbeat News

Stock Prices

BDTX

In the last quarter, Black Diamond Therapeutic (NASDAQ:BDTX) received 2 bullish, 3 somewhat bullish, and 1 indifferent rating from analysts. The average price target is $9.0, a significant increase from the previous target of $2.5, implying an upside compared to the current price of $3.55.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 4:00 pm

TMUS

Over the past 10 years, T-Mobile US (NASDAQ:TMUS) has outperformed the market by 8.64% on an annualized basis, producing an average annual return of 18.72%. If an investor had bought $100 of TMUS stock 10 years ago, it would be worth $565.55 today. T-Mobile US currently has a market capitalization of $164.14 billion.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 4:00 pm

CYBR

Over the past 3 months, 21 analysts have published their opinion on CyberArk Software (NASDAQ:CYBR) stock. The majority of these analysts are bullish or somewhat bullish, with an average price target of $187.71, implying an upside from the current price of $166.81. The average price target has increased by 5.53% over the past month.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 4:00 pm

HD

Home Depot (NYSE:HD) has outperformed the market over the past 15 years by 9.13% on an annualized basis, producing an average annual return of 18.5%. If an investor had bought $1000 of HD stock 15 years ago, it would be worth $11,848.64 today.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 4:00 pm

CPT

Analysts have provided various ratings for Camden Prop Trust (NYSE:CPT) within the last quarter, with 1 bullish, 1 somewhat bullish, 3 indifferent, and 1 somewhat bearish. The average 12-month price target for CPT is $124.67, an increase of 1.36% from the previous average price target of $123.00.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 4:00 pm

OFIX

Stifel analyst Mathew Blackman has downgraded Orthofix Medical (NASDAQ:OFIX) from Buy to Hold and lowered the price target from $30 to $16.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 3:59 pm

CVX

LNG

SHEL

XOM

The energy sector is in the spotlight due to fluctuations in oil prices and a resurgent interest in heating oil. Liquefied natural gas (LNG) is expected to gain significant attention due to volatile inventory levels in the EU, labor disruptions in supply hubs, and geopolitical tensions. The U.S., a major player in the global LNG market, exported 3.8 trillion cubic feet of LNG in 2022. Last week, a dip in EU LNG inventories and Chevron Australia’s LNG strikes led to a spike in the price of UK Natural Gas and Henry Hub futures. Chevron (NYSE:CVX), ExxonMobil (NYSE:XOM), Cheniere Energy (NYSEAMERICAN: LNG), and Shell (NYSE:SHEL) are mentioned in the context of the LNG market.

Portfolio Pulse from Kevin Green

September 12, 2023 | 3:52 pm

JPM

A significant amount of unusual options activity has been observed for JPMorgan Chase (NYSE:JPM), with a bearish stance being taken by a majority of investors. Of the 11 strange trades detected, 63% were bearish and 36% bullish. The total amount for the 7 puts was $326,562 and for the 4 calls was $189,125. The targeted price range for JPMorgan Chase over the last 3 months has been $115.0 to $150.0. The stock is currently up 0.89% at $145.75. Several financial institutions have given their ratings and price targets for JPM.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:47 pm

AVGO

A significant bearish stance has been taken on Broadcom (NASDAQ:AVGO) by a large investor or institution, as indicated by unusual options activity. The sentiment among these big-money traders is 75% bearish and 25% bullish. The whales have been targeting a price range from $510.0 to $900.0 for Broadcom over the last 3 months. The price of AVGO is currently down -1.1% at $849.73. Several financial institutions have maintained their ratings on Broadcom, with price targets ranging from $900 to $1000.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:47 pm

LLY

A significant bullish stance has been taken on Eli Lilly (NYSE:LLY) by an unknown entity, possibly an institution or wealthy individual. This was noticed through publicly available options history. The overall sentiment of these big-money traders is split between 50% bullish and 50% bearish. Whales have been targeting a price range from $550.0 to $680.0 for Eli Lilly over the last 3 months. The current price of LLY is $595.43. Morgan Stanley, Cantor Fitzgerald, and Argus Research have maintained their Overweight and Buy ratings on Eli Lilly with price targets of $640, $630, and $620 respectively.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:46 pm